Dianthus Therapeutics, Inc. (DNTH): Net Income
-$162.34M
Year ended 2025-12-31
-$192.25M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$162.34M | n/m | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | -$84.97M | n/m | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | -$43.55M | n/m | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | -$28.48M | n/m | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | -$71.14M | n/m | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | -$74.94M | n/m | 2022-03-08, From 2020-01-01 |
| 2019-12-31 | -$76.77M | n/m | 2021-03-03, From 2019-01-01 |
| 2018-12-31 | -$57.52M | n/m | 2020-03-03, From 2018-01-01 |
| 2017-12-31 | -$35.49M | n/m | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | -$9.43M | n/a | 2019-03-19, From 2016-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | -$162.34M | n/m |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | -$3.53M | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | -$9.63M | n/m |
| Bio Essence Corp (BIOE) | 2025-12-31 | $896.2K | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.46M | n/m |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | -$40.95M | n/m |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$130.30M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$143.44M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$28.62M | n/m |
Compare DNTH, KRSA, LPCN, BIOE side by side · Screen every company in Pharmaceutical Preparations ↗